Previous studies in Saudi Arabia using genetic variants of ADIPOQ have examined coronary artery disease (CAD) in T2DM [33], MetS [34], and PCOS [35] and insulin resistance in non-diabetic Saudi women [36], as well as T2DM [37] and colon cancer [39]. This evidence concerns the gene ADIPOQ and metabolic syndrome.